Table of Contents Table of Contents
Previous Page  460 / 1096 Next Page
Information
Show Menu
Previous Page 460 / 1096 Next Page
Page Background

S445

ESTRO 36

_______________________________________________________________________________________________

Material and Methods

10 HN oropharynx consecutive patients treated with PBS

PT underwent prospective evaluation computer

tomography scans (eCTs) during their course of treatment

(average 4 eCTs per patient). The robustness of the

treatment plans containing two-posterior oblique(PO) PBS

fields (2PBS), contingency VMAT plans (2 arcs) and

retrospectively generated 3-field PBS plans (3PBS) was

evaluated against anatomy changes and residual setup

uncertainties via evaluation plans generated on eCTs.

3PBS plan matched two PO fields (same to 2PBS) with an

anterior field at thyroid notch level in order to treat the

lower neck nodal target. Plan robustness was assessed

based on the accumulated dose through deformable image

and dose registration between treatment and evaluation

plans using VelocityAI. The D98% dosimetric indicator of

target coverage and OARs planning constraints were used

to evaluate the plan robustness. Changes over 5% in target

coverage, excessive cord dose and/or clinical decision

triggered proton replan or the use of the VMAT

contingency plan.

Results

The average change of D98% in the accumulated plans for

2PBS, 3PBS and VMAT were:4.1%±4.8%, -0.1%±0.8% and -

2%±3.2% for low risk CTV, -1.7±1.8%, -0.5±0.8% and -

0.73±1.2% for high risk CTV, -0.2%±0.2%, -0.1%±0.1% and

-0.4%±1.3% for gross CTV respectively. The main source of

coverage loss at low risk CTV level for 2PBS was found to

be due to variable soft tissue deformation of the posterior

neck for elderly or short neck patients leading to

replanning for 2 out10 patients. OARs robustness was

maintained within planning constraints.

Conclusion

2PBS plans were not consistently robust relative to target

coverage due to variable folding neck tissue, and

therefore it should be cautiously employed for elderly and

short neck patients. 3PBS was proved to be consistently

robust, similarly with VMAT.

PO-0828 Stereotactic body radiotherapy (SBRT) for

localised prostate cancer on the MR-Linac

A. Pathmanathan

1

, A. Mitchell

2

, K. Thomas

3

, D.

Henderson

2

, S. Nill

1

, U. Oelfke

1

, R. Huddart

1

, N. Van As

2

,

A. Tree

2

1

Institute of Cancer Research, Radiotherapy and Imaging,

London, United Kingdom

2

The Royal Marsden NHS Foundation Trust, Department

of Radiotherapy, London, United Kingdom

3

The Royal Marsden NHS Foundation Trust, Statistics

Unit, London, United Kingdom

Purpose or Objective

As the estimated alpha-beta ratio for prostate cancer is

low (1), moderate hypofractionation has been shown to be

isoeffective (2). The MR-Linac (MRL) combines an MR

scanner and linac allowing intrafractional tracking of the

target (3). However, dose distributions are affected by the

magnetic field (4). The first Elekta system MRL (1.5T/

7MV) will deliver step-and-shoot intensity modulated

radiotherapy (IMRT), a technique rarely used for

stereotactic body radiotherapy (SBRT). This planning study

assesses whether adequate dose distributions for MRL-

based prostate SBRT are possible with comparison to non-

MRL based planning techniques: IMRT, volumetric

modulated arc therapy (VMAT) and CyberKnife.

Material and Methods

Using planning CT scans acquired for ten patients with

localised prostate cancer, clinical target volume (CTV)

was defined as prostate plus proximal 1cm of seminal

vesicles. The planning target volume (PTV) was created by

addition of a 5mm isotropic margin, except 3mm

posteriorly. For the MRL, 5, 7 and 9-field step-and-shoot

IMRT plans were created to deliver 36.25Gy in 5 fractions

to the PTV with an integrated dose of 40Gy in 5 fractions

to the CTV using Monaco 5.19 (research version, Elekta AB,

Stockholm, Sweden). Non-MRL comparison plans included:

7-field 6MV IMRT for a conventional Elekta Agility linac

(Elekta AB, Stockholm, Sweden), 6MV FFF single 360° arc

VMAT using Pinnacle 9.10 (Philips Radiation Oncology

Systems, Fitchburg, WI) for a non-MRL and CyberKnife

treatment using Multiplan (Accuray inc, Sunnyvale, CA).

Plans were acceptable if the 16 dose constraints of the

PACE trial (NCT01584258) were achieved, without a major

variation to the protocol.

Results

Clinically acceptable 7-field IMRT MRL plans (see Figure 1)

were achieved in all ten patients. Clinically acceptable

plans were also achieved for all ten patients using 9-field

IMRT, non-MRL 7-field IMRT, non-MRL VMAT and

CyberKnife treatment. Clinically acceptable 5-field IMRT

MRL plans were only possible in seven patients. Table 1

summarises the number of exceeded constraints, mean

rectal doses and mean bladder V37Gy for each plan type.

Given the small patient group, exploratory ANOVA

analyses were undertaken for the number of co nstraints

missed, the rectum D1cc and the two most challenging

constraints to achieve- rectum V36Gy and bladder V37Gy.

For the MRL, 5-field IMRT MRL plans performed

significantly worse in all these analyses compared to 7-

field IMRT. 7-field IMRT MRL plans had significantly lower

rectal doses compared to CyberKnife plans. No significant

differences were seen between 9-field IMRT MRL plans and

non-MRL VMAT plans compared to 7-field IMRT.

Conclusion

MRL IMRT plans for prostate SBRT achieved the PACE trial

constraints in all patients with 9-field appearing similar to

7-field IMRT. 5-field IMRT in this set-up appears inferior

for the MRL. All platforms could produce clinically

acceptable plans. Further work is needed for dosimetric

validation and feasibility of MRL delivery.

PO-0829 Robustness of IMRT and VMAT for

interfraction motion in locoregional breast irradiation

R. Canters

1

, M. Kunze-Busch

1

, P. Van Kollenburg

1

, M.

Kusters

1

, P. Poortmans

1

, R. Monshouwer

1

1

Radboud University Medical Center, Radiation oncology,

Nijmegen, The Netherlands

Purpose or Objective

Conventional techniques for locoregional breast

irradiation using field abutment are challenging, even

more in combination with breath-hold irradiation and with

hypofractionation, since over- or underdosage may occur

more consistently in the abutment region in these

circumstances. IMRT and VMAT techniques are likely to